InvestorsHub Logo
Followers 5
Posts 861
Boards Moderated 0
Alias Born 09/28/2012

Re: maumar post# 5788

Monday, 01/13/2020 10:32:24 PM

Monday, January 13, 2020 10:32:24 PM

Post# of 8557
Economic Moat

Anna Baran, Eq. Analyst, 03 December 2019

Now that Darzalex (daratumumab) has become clearly entrenched in the standard of care for multiple myeloma (MM)patients, we are upgrading Genmab's moat from none to narrow. We think it is highly unlikely that Darzalex gets dethroned from its dominant market position in the next 10 years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News